Clinical reference
Antirheumatic · Tumor necrosis factor (TNF) receptor p75 Fc fusion protein; immunomodulatory agent · Rheumatology, Dermatology, Pediatrics
Etanercept is a recombinant human tumor necrosis factor (TNF) receptor p75 Fc fusion protein that acts as a TNF inhibitor, used for treatment of juvenile idiopathic arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Prefilled single-use injections: 25 mg (0.5 mL) and 50 mg (1 mL) containing sucrose and L-ar…